Advertisement

Topics

Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients

2010-07-15 17:00:00 | BioPortfolio

Summary

The purpose of this study is to evaluate if DE-101 ophthalmic suspension will safely and effectively improve signs and or symptoms of dry eye disease.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Conditions

Dry Eye

Intervention

DE-101 ophthalmic suspension, DE-101 ophthalmic suspension, DE-101 ophthalmic suspension vehicle

Location

Inglewood
California
United States

Status

Recruiting

Source

Santen Inc.

Results (where available)

View Results

Links

Published on BioPortfolio: 2010-07-15T17:00:00-0400

Clinical Trials [978 Associated Clinical Trials listed on BioPortfolio]

Study to Assess the Safety and Efficacy of BOL-303242-X Ophthalmic Suspension in Dry Eye Syndrome

The objective of this study is to identify the concentration and daily dosing frequency of BOL-303242-X ophthalmic suspension in treating dry eye syndrome over a 12 week dosing period.

Loteprednol Etabonate Opthalmic Suspension for the Treatment of Dry Eye

This was a single-center, randomized, double-masked, placebo-controlled, parallel-group, 4-visit, CAE (Controlled Adverse Environment) study lasting approximately 4 weeks. Subjects were ra...

Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease

The primary purpose of this study is to determine the efficacy and safety of KPI-121 0.25% ophthalmic suspension compared to vehicle (placebo) in subjects who have a documented clinical di...

Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension to Azopt® 1% Ophthalmic Suspension In the Treatment of Chronic Open Angle Glaucoma or Ocular Hypertension in Both Eyes

This is a randomized, double blind, two-arm, parallel group, active controlled bioequivalence study, at multiple clinical trial sites designed to demonstrate bioequivalence of Brinzolamide...

Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease

The primary purpose of this study is to determine the efficacy and safety of KPI-121 0.25% ophthalmic suspension compared to vehicle (placebo) in subjects who have a documented clinical di...

PubMed Articles [1624 Associated PubMed Articles listed on BioPortfolio]

Symmetry of Upper Eyelid Contour After Unilateral Blepharoptosis Repair With a Single-strip Frontalis Suspension Technique.

To analyze the upper eyelid contour of patients with unilateral congenital ptosis who underwent single-strip frontalis suspension.

Stability of an Alcohol-free, Dye-free Hydrocortisone (2 mg/mL) Compounded Oral Suspension.

The stability of hydrocortisone in a commercially available dye-free oral vehicle was monitored to establish a beyond-use date for hydrocortisone oral suspension 2 mg/mL. Hydrocortisone oral suspensio...

Nepafenac Ophthalmic Suspension 0.3% for the Management of Ocular Pain After Photorefractive Keratectomy.

To investigate the effect of nepafenac 0.3% in a once daily dosage regarding pain and healing after photorefractive keratectomy (PRK).

Ophthalmic Manifestations of Allergic Fungal Sinusitis.

To study the ophthalmic manifestations of patients with allergic fungal sinusitis (AFS) and evaluate the importance of early diagnosis and management in preventing the possible future complications of...

Ophthalmic abnormalities of Pai syndrome: A case report and review of literature.

Medical and Biotech [MESH] Definitions

A sensory branch of the trigeminal (5th cranial) nerve. The ophthalmic nerve carries general afferents from the superficial division of the face including the eyeball, conjunctiva, upper eyelid, upper nose, nasal mucosa, and scalp.

Application of pharmaceutically active agents on the tissues of the EYE.

A readily reversible suspension of sensorimotor interaction with the environment, usually associated with recumbency and immobility.

One of the MUSCARINIC ANTAGONISTS with pharmacologic action similar to ATROPINE and used mainly as an ophthalmic parasympatholytic or mydriatic.

Persons academically trained to care for patients with eye diseases or structural defects of the eye, under the supervision of an ophthalmologist.

More From BioPortfolio on "Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial